Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 20 citing articles:

A Review of the Recent Development in the Synthesis and Biological Evaluations of Pyrazole Derivatives
Oluwakemi Ebenezer, Michael Shapi, Jack A. Tuszyński
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1124-1124
Open Access | Times Cited: 106
Synthesis of new pyridine-thiazolidin-4-one and pyridine-pyrazole-thiazolidin-4-one conjugates: Molecular modelling and docking as antimicrobial agents
Hana M. Abumelha, Omar M. Alatawi, Ali Hamzah Alessa, et al.
Journal of Molecular Structure (2024) Vol. 1309, pp. 138233-138233
Closed Access | Times Cited: 10
Efficient and Recoverable Bio-Organic Catalyst Cysteine for Synthesis, Docking Study, and Antifungal Activity of New Bio-Active 3,4-Dihydropyrimidin-2(1H)-ones/thiones Under Microwave Irradiation
Nadia A. A. Elkanzi, Asmaa M. Kadry, Rasha M. Ryad, et al.
ACS Omega (2022) Vol. 7, Iss. 26, pp. 22839-22849
Open Access | Times Cited: 31
Targeting tumor cells with pyrazolo[3,4-d]pyrimidine scaffold: A literature review on synthetic approaches, structure activity relationship, structural and target-based mechanisms
Mohamed A. Abdelgawad, Nadia A. A. Elkanzi, AbdElAziz A. Nayl, et al.
Arabian Journal of Chemistry (2022) Vol. 15, Iss. 5, pp. 103781-103781
Open Access | Times Cited: 20
Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights
Tarfah Al‐Warhi, Ahmed M. El Kerdawy, Mohamed A. Said, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 1457-1471
Open Access | Times Cited: 20
A Molecular Insight into Pyrazole Congeners as Antimicrobial, Anticancer, and Antimalarial Agents
Dipanjan Karati, Kakasaheb Mahadik, Piyush Trivedi, et al.
Medicinal Chemistry (2022) Vol. 18, Iss. 10, pp. 1044-1059
Closed Access | Times Cited: 14
Green Design, Synthesis, and Molecular Docking Study of Novel Quinoxaline Derivatives with Insecticidal Potential against Aphis craccivora
Mariam Azzam Alanazi, Wael A. A. Arafa, Ibrahim O. Althobaiti, et al.
ACS Omega (2022) Vol. 7, Iss. 31, pp. 27674-27689
Open Access | Times Cited: 14
In Sight into Innovative Cancer Therapeutic Approach Based on Nanotechnology: Chitosan (CS) / Polyvinyl alcohol (PVA) Films loaded with Synthesized Bisthiazole Derivative for Cancer Treatment
Manar Ayman, Sobhi M. Gomha, Magda A. Abdallah, et al.
Egyptian Journal of Chemistry (2023) Vol. 66, Iss. 13, pp. 1997-2011
Open Access | Times Cited: 5
Review of the recent advances of pyrazole derivatives as selective COX-2 inhibitors for treating inflammation
Mohammed M. Ghoneim, Mohamed A. Abdelgawad, Nadia A. A. Elkanzi, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 1
New Pyrazolothiazole as Potential Wnt/β‐Catenin Inhibitors: Green Synthesis, Characterization, Antimicrobial, Antioxidant, Antineoplastic Evaluation, and Molecular Docking Study
Ahmed A. Noser, Mohamed H. Baren, Seham A. Ibrahim, et al.
ChemistrySelect (2023) Vol. 8, Iss. 12
Closed Access | Times Cited: 4
Design, Synthesis, Docking Study of Pyrazolohydrazinopyrimidin‐4‐one Derivatives and Their Application as Antimicrobials
Ruba A. Alolayan, Nadia A. A. Elkanzi, Hajer Hrichi, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 5
Closed Access | Times Cited: 3
Thiochromene candidates: design, synthesis, antimicrobial potential and in silico docking study
Rania B. Bakr, Islam H. El Azab, Nadia A. A. Elkanzi
Journal of the Iranian Chemical Society (2021) Vol. 19, Iss. 4, pp. 1413-1423
Closed Access | Times Cited: 7
Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies
Ahmed K. B. Aljohani, Waheed Ali Zaki El Zaloa, Mohamed Alswah, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 15026-15026
Open Access | Times Cited: 2
Design, Synthesis, andIn SilicoMolecular Docking Study of Some Novel Thiochromene Derivatives with Antimicrobial Potential
Nadia A. A. Elkanzi, Islam H. El Azab, Rania B. Bakr
Polycyclic aromatic compounds (2022) Vol. 42, Iss. 9, pp. 6760-6779
Closed Access | Times Cited: 4
Construction and Docking Studies of Novel Pyrimido[4,5‐b]quinolines as Antimicrobial Agents
Rania B. Bakr, Islam H. El Azab, Nadia A. A. Elkanzi
Chemistry & Biodiversity (2024) Vol. 21, Iss. 6
Closed Access
Multicomponent reaction strategy to heterocyclic compounds in anticancer drug design
Suman Majee, Sakshi Priya, Vaibhav Kumar, et al.
Elsevier eBooks (2024), pp. 551-595
Closed Access
Insight into the therapeutic potential of pyrazole‐thiazole hybrids: A comprehensive review
Garima Sumran, Manisha Sharma, Ranjana Aggarwal
Archiv der Pharmazie (2024)
Closed Access
Insights Into the Synthetic Strategies, Biological Activity, and Structure- Activity Relationship of Pyridine and Analogs: A Review
Aprajita Matthew, Rajnish Kumar, Avijit Mazumder, et al.
Letters in Organic Chemistry (2023) Vol. 20, Iss. 11, pp. 1025-1054
Closed Access | Times Cited: 1
Novel 1,2-Thiazine-Pyridine Hybrid: Design, Synthesis, Antioxidant Activity and Molecular Docking Study
Rania B. Bakr, Nadia A. A. Elkanzi
Letters in Drug Design & Discovery (2022) Vol. 19, Iss. 8, pp. 675-690
Closed Access | Times Cited: 2
Review of the Synthesis, Reactions and Pharmaceutical Potential of Pyrido [2,3-d]Pyrimidine Derivatives
Tamer El Malah, Randa E. Abdel Mageid, Ahmed H. Shamroukh
Current Organic Chemistry (2023) Vol. 27, Iss. 4, pp. 260-281
Closed Access
Page 1

Scroll to top